- Home
- Products
Asparlas (Calaspargase pegol-mknl)
Asparlas (Calaspargase pegol-mknl)
- Medicine Name: Asparlas
- Generic Name: Calaspargase pegol-mknl
- Dosage Form & Strength: Injection – 3,750 units/5 mL (750 units/mL) in a single-dose vial
- Manufactured By: Servier Pharmaceuticals LLC
Asparlas is an asparagine-specific enzyme used as part of a multi-agent chemotherapy regimen for the treatment of acute lymphoblastic leukemia (ALL) in pediatric and young adult patients aged 1 month to 21 years.
Recommended Dosage:
- 2,500 units/m² administered intravenously no more than once every 21 days
- Premedication with acetaminophen, diphenhydramine (H1-blocker), and famotidine (H2-blocker) is recommended 30–60 minutes prior to reduce the risk of infusion and hypersensitivity reactions
Hypersensitivity Reactions: Grade 3/4 reactions, including anaphylaxis, may occur. Monitor for swelling, rash, bronchospasm, and hypotension.
Pancreatitis: May be life-threatening. Monitor amylase/lipase levels. Discontinue immediately if suspected.
Thrombosis: Serious thrombotic events have been reported. Discontinue in such cases.
Hemorrhage: Monitor for increased PT, PTT, and hypofibrinogenemia; assess coagulation parameters if bleeding symptoms occur.
Liver Toxicity: Monitor bilirubin and transaminases weekly during treatment and up to 6 weeks after the last dose.
Pregnancy Risk: May cause fetal harm. Conduct pregnancy testing before initiation. Avoid breastfeeding during treatment and for 3 months after the last dose.
Required for Import to India:
- Valid medical prescription
- Diagnostic reports confirming ALL diagnosis
- Government-issued patient ID
Availability in India:
Asparlas is a prescription-only drug available under India’s Named Patient Program. Global Rare Meds facilitates access for hospitals, doctors, and patients in cities such as Mumbai, Delhi, Bengaluru, Hyderabad, Kolkata, Pune, Chennai, and more.
Order Confirmation:
Begins after receiving a valid prescription and any required import documentation.
📧 info@globalraremeds.com
📞 +91-99675 15602 (Call/WhatsApp)
Global Rare Meds imports Asparlas (Calaspargase pegol-mknl) from certified international suppliers in the USA, Canada, Europe, and Australia. All prescriptions are processed via our licensed fulfillment center in Ambernath, Thane District, ensuring:
- Verified cold-chain shipping (where applicable)
- Registered pharmacist oversight
- Secure, compliant delivery to your doorstep
Q: What is the generic name of Asparlas®?
A: Calaspargase pegol-mknl
Q: Who manufactures Asparlas®?
A: Servier Pharmaceuticals LLC
Q: Is Asparlas® FDA-approved?
A: Yes, Asparlas received FDA approval on December 20, 2018.
Q: What is the form and strength of Asparlas®?
A: Injection – 3,750 units/5 mL (750 units/mL) for IV use
Q: What are common side effects of Asparlas®?
A: Elevated bilirubin, transaminase levels, pancreatitis, and abnormal coagulation studies
Q: How should Asparlas® be stored?
A: Store at 2°C to 8°C in the original carton to protect from light. Unopened vials may be stored at 15°C to 25°C for up to 48 hours. Do not freeze or shake.
Q: What is the price of Asparlas® in India?
A: Pricing varies. Contact info@globalraremeds.com or +91-99675 15602 for the most accurate quote.
Q: Can Asparlas® be purchased online in India?
A: Yes. Global Rare Meds facilitates the legal, authentic procurement of Asparlas through valid prescription and regulatory compliance.
Contact Patient Support
If you have questions about your order, need assistance with documentation, or require support with medicine availability, our GlobalRareMeds Patient Support Team is here to help. We aim to respond within 24 hours, Monday to Friday, between 9:00 AM and 10:00 AM IST.
info@globalraremeds.com
Phone
+91 99675 15602
+91 99675 15602
Disclaimer
All trademarks, brands, and product names featured on this website are the property of their respective owners. GlobalRareMeds does not claim ownership or affiliation unless explicitly stated. Our role is to provide reliable and transparent access to difficult-to-source medicines through named-patient import services, based on valid prescriptions and legal requirements.
The product-related content on this website is shared to the best of our knowledge, compiled from publicly available sources and regulatory documents. However, GlobalRareMeds does not guarantee the accuracy, completeness, or timeliness of this information. We strongly recommend that all medical decisions, including usage and dosage, be made only in consultation with the prescribing doctor. GlobalRareMeds assumes no responsibility for consequences arising from reliance on this information without appropriate medical guidance
